SMTL ID : 2oj9.1

Structure of IGF-1R kinase domain complexed with a benzimidazole inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x BMI: 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE(Non-covalent)

BMI.1: 14 residues within 4Å: Chain A: L.26, G.27, Q.28, V.34, A.52, M.100, E.101, L.102, M.103, T.104, R.105, G.106, M.163, T.178 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.26, A:L.26, A:A.52 Hydrogen bonds: A:E.101, A:M.103

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Velaparthi, U. et al., Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R). Bioorg.Med.Chem.Lett. (2007)

Release Date

2007-05-01

Peptides

Insulin-like growth factor 1 receptor precursor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD221 antigen): A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Insulin-like growth factor 1 receptor precursor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD221 antigen)

Related Entries With Identical Sequence